Cardiomyopathy due to anthracyclines
MONDO:002265322 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsBroader categories
-
New trial aims to shield hearts from chemo side effects
Prevention Not yet recruitingThis study tests whether a drug called sotagliflozin can prevent heart, muscle, and fat damage caused by a common type of chemotherapy (anthracycline) in people with newly diagnosed lymphoma. About 60 adults who are scheduled to receive high-dose anthracycline will take either th…
Phase: PHASE2 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Prevention
Last updated Jun 27, 2026 12:30 UTC
-
Heart shield: statin may guard against chemo damage in breast cancer
Prevention Not yet recruitingThis study tests whether taking rosuvastatin, a cholesterol-lowering drug, can prevent heart damage caused by anthracycline chemotherapy in women with breast cancer. Four hundred participants will receive either rosuvastatin or a placebo daily for 12 months. The main goal is to s…
Phase: PHASE4 • Sponsor: Shiraz University of Medical Sciences • Aim: Prevention
Last updated Jun 27, 2026 08:03 UTC
-
New study aims to predict heart side effects in kids treated for cancer
Knowledge-focused Not yet recruitingThis study will check if certain blood markers can predict heart damage in children and teens who had anthracycline chemotherapy for cancer. Researchers will compare blood tests and heart imaging results from 40 survivors and healthy volunteers. The goal is to find early warning …
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:00 UTC